Can-Fite BioPharma (CANF) Tops Q1 EPS by 19c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| CAN-FITE BIOPHARMA LTD. (NYSE: CANF) | Delayed: 1.67 +0.05 (3.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.62 | 52 Week High | $3.89 | |||
| Open | $1.50 | 52 Week Low | $1.85 | |||
| Day High | $1.68 | P/E | N/A | |||
| Day Low | $1.50 | EPS | $0.00 | |||
| Volume | 14,117 | |||||
